Alkem Labs Daman facility gets 3 major, few minor observations from Malta Medicines Authority

Mumbai: Alkem Labs has announced that the Malta Medicines Authority has concluded an inspection with three major observations and a few minor observations at the Company’s manufacturing facility located at Daman,…

Continue ReadingAlkem Labs Daman facility gets 3 major, few minor observations from Malta Medicines Authority

Uncontrolled T2DM in India and Application of Trusted Molecules Empagliflozin, Sitagliptin, and Metformin Coming Together

The Growing Burden of Uncontrolled T2DM in India: The burden of diabetes in India has risen markedly, yet only around 7% of individuals with diagnosed T2DM meet combined treatment targets…

Continue ReadingUncontrolled T2DM in India and Application of Trusted Molecules Empagliflozin, Sitagliptin, and Metformin Coming Together

Colchicine Linked to Reduced Cardiovascular Events in Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA): AHJP December 2025 Study Finds

A recent large real-world cohort showed a trend toward reduced cardiovascular outcomes in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) who were on colchicine. A portion of this…

Continue ReadingColchicine Linked to Reduced Cardiovascular Events in Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA): AHJP December 2025 Study Finds

Ultra-Short β-Blockers Deliver Rapid Stability in AF-Triggered Acute Heart Failure, AHJP December 2025 Review

A recent review concluded that acute heart failure (HF) induced by rapid atrial fibrillation (rapid AF) presents a critical dilemma due to conflicting guideline recommendations on heart rate control. While…

Continue ReadingUltra-Short β-Blockers Deliver Rapid Stability in AF-Triggered Acute Heart Failure, AHJP December 2025 Review